Neutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis

Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) with limited biomarkers for early detection. While neutrophils contribute to SLE pathogenesis, their phenotypic heterogeneity in disease remains poorly characterized. Here, we used mass cytometry to profile blood neutrophils from patients with biopsy-confirmed proliferative LN and healthy controls. We identified a distinct population of activated neutrophils, marked by surface expression of lysosomal-associated membrane protein 1 (LAMP1/CD107a), that was virtually absent in healthy individuals. We demonstrate that LAMP1 resides intracellularly in resting neutrophils and translocates to the cell surface upon activation. Transcriptomic analysis revealed no difference in LAMP1 mRNA expression between patients with SLE and controls, confirming that surface LAMP1 reflects neutrophil activation rather than increased transcription. Soluble LAMP1 was significantly elevated in serum from patients with SLE compared with controls, with the highest levels in proliferative LN. In a large cohort of 225 patients with LN, urinary LAMP1 correlated with glomerular filtration rate, proteinuria, and histological activity indices. Together, our findings reveal LAMP1 as a marker of neutrophil activation in SLE and identify serum and urinary LAMP1 as potential noninvasive biomarkers for proliferative LN.

Authors

Institutions

Publication Details

Journal
European Journal of Immunology
Published
2025-08-01
DOI
https://doi.org/10.1002/eji.70022
Primary Topic
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis

Panagiotis Garantziotis, James A. Lederer, Andrea Fava, Ricardo Grieshaber‐Bouyer et al.
European Journal of Immunology
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
article

Neutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis

Panagiotis Garantziotis, James A. Lederer, Andrea Fava, Ricardo Grieshaber‐Bouyer, Frank Y. Huang, Georg Andreas Schett, Lennard Ostendorf, Deepak A. Rao
article en

Abstract

Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) with limited biomarkers for early detection. While neutrophils contribute to SLE pathogenesis, their phenotypic heterogeneity in disease remains poorly characterized. Here, we used mass cytometry to profile blood neutrophils from patients with biopsy-confirmed proliferative LN and healthy controls. We identified a distinct population of activated neutrophils, marked by surface expression of lysosomal-associated membrane protein 1 (LAMP1/CD107a), that was virtually absent in healthy individuals. We demonstrate that LAMP1 resides intracellularly in resting neutrophils and translocates to the cell surface upon activation. Transcriptomic analysis revealed no difference in LAMP1 mRNA expression between patients with SLE and controls, confirming that surface LAMP1 reflects neutrophil activation rather than increased transcription. Soluble LAMP1 was significantly elevated in serum from patients with SLE compared with controls, with the highest levels in proliferative LN. In a large cohort of 225 patients with LN, urinary LAMP1 correlated with glomerular filtration rate, proteinuria, and histological activity indices. Together, our findings reveal LAMP1 as a marker of neutrophil activation in SLE and identify serum and urinary LAMP1 as potential noninvasive biomarkers for proliferative LN.

European Journal of ImmunologyVol. 55(8)
Brigham and Women's Hospital (US), Harvard University (US), Johns Hopkins University (US), Heidelberg University (DE), Johns Hopkins Medicine (US), University Hospital Heidelberg (DE), Leibniz Association (DE), Humboldt-Universität zu Berlin (DE), Universitätsklinikum Erlangen (DE), German Rheumatism Research Centre (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, Sanofi, Rheumatology Research Foundation, Lupus Research Alliance, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Else Kröner-Fresenius-Stiftung, Boehringer Ingelheim Stiftung, Berlin Institute of Health, National Institutes of Health, Takeda Pharmaceuticals International, Leibniz-Gemeinschaft, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Good health and well-being
Openalex Percentile: Top 79%
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.